AbbVie’s (ABBV) Allergan Aesthetics is to acquire Soliton (SOLY) plus its Rapid Acoustic Pulse device, which was recently approved by the U.S.
AbbVie (ABBV) is off to a good start going by its impressive 1Q 2021 results. Net revenues increased by 51% year-over-year to $13.
AbbVie (ABBV) announced on Friday that it has entered into a collaboration to develop a novel antibody therapeutic to prevent and treat COVID-19, …
Drugmaker AbbVie (ABBV) has announced that it has submitted applications for a new indication for Rinvoq (upadacitinib; 15 mg, once daily) for the treatment …
AbbVie (ABBV) announced on Monday that it has entered into a partnership with Jacobio Pharmaceuticals, to jointly develop and commercialize SHP2 inhibitors, which target a …
AbbVie’s (ABBV) plan to close the $63 billion Allergan (AGN) deal this month appears on track following the announcement that they have received …
Analysts are weighing in today on healthcare giants Gilead Sciences, Inc. (NASDAQ:GILD) and AbbVie Inc (NYSE:ABBV).
AbbVie Inc (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2016. “We delivered another strong quarter, with EPS growth ahead …
AbbVie Inc (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2016. “AbbVie continues to deliver on our long-term strategy, as demonstrated …
By Dirk S. Leach Today, long term investors are challenged in navigating the course and lining up that long drive for a investment …
